---
figid: PMC11602477__fimmu-15-1486680-g001
figtitle: Wnt/Beta-catenin pathway in CSCs
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC11602477
filename: fimmu-15-1486680-g001.jpg
figlink: /pmc/articles/PMC11602477/figure/F1/
number: F1
caption: Wnt/β-catenin pathway in CSCs. (By Figdraw). Wnt ligands bind to cell surface
  receptors, leading to the stabilization and accumulation of β-catenin in the cytoplasm.
  Subsequently, β-catenin translocates into the nucleus, where it acts as a coactivator
  for transcription factors of the T-cell factor/lymphoid enhancer factor (TCF/LEF)
  family. This leads to the activation of target gene expression, which regulates
  cell proliferation, survival, and differentiation. Dysregulation of the Wnt/β-catenin
  pathway has been implicated in various diseases, including cancer, where aberrant
  activation of the pathway contributes to tumor initiation, progression, and metastasis
papertitle: The roles of cancer stem cells and therapeutic implications in melanoma
reftext: Xiaoli Mu, et al. Front Immunol. 2024;15(NA).
year: '2024'
doi: 10.3389/fimmu.2024.1486680
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media SA
keywords: melanoma stem cells | surface marker | signaling pathway | tumor microenvironment
  | therapeutic advances
automl_pathway: 0.9511201
figid_alias: PMC11602477__F1
figtype: Figure
redirect_from: /figures/PMC11602477__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11602477__fimmu-15-1486680-g001.html
  '@type': Dataset
  description: Wnt/β-catenin pathway in CSCs. (By Figdraw). Wnt ligands bind to cell
    surface receptors, leading to the stabilization and accumulation of β-catenin
    in the cytoplasm. Subsequently, β-catenin translocates into the nucleus, where
    it acts as a coactivator for transcription factors of the T-cell factor/lymphoid
    enhancer factor (TCF/LEF) family. This leads to the activation of target gene
    expression, which regulates cell proliferation, survival, and differentiation.
    Dysregulation of the Wnt/β-catenin pathway has been implicated in various diseases,
    including cancer, where aberrant activation of the pathway contributes to tumor
    initiation, progression, and metastasis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ctnnb1
  - gsk3ba
  - gsk3ab
  - rho
  - rnd2
  - cki
  - apc
  - tafazzin
  - mapk8b
  - elk4
  - nin
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - BMP1
  - PRCP
  - PGPEP1
  - CDH1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - SLC25A15
  - CTNNB1
  - CSNK2A1
  - CSNK2A2
  - CSNK2B
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
  - AXIN1
  - AXIN2
  - YAP1
  - GSK3A
  - GSK3B
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - CHKA
  - APC
  - PROC
  - TAFAZZIN
  - WWTR1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - ROCK1
  - ROCK2
  - MAPK8
  - MAPK9
  - MAPK10
  - HNF4A
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - NIN
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - INTU
---
